Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/5304| High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019. | |
| Cao Wei. Liu Xiaosheng. Bai Tao. Fan Hongwei. Hong Ke. Song Hui. Han Yang. Lin Ling. Ruan Lianguo. Li Taisheng. | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| 10.1093/ofid/ofaa102 | |
| The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19. | |
| Open Forum Infectious Diseases | |
| 2020 | |
| Artículo | |
| https://academic.oup.com/ofid/article-pdf/7/3/ofaa102/32987821/ofaa102.pdf | |
| Inglés | |
| VIRUS RESPIRATORIOS | |
| Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| 1108687.pdf | 431.74 kB | Adobe PDF | Visualizar/Abrir |